Skip to main content

BIOHARVEST SCIENCES INC.

corporate_fare Company Profile

BIOHARVEST SCIENCES INC.

BHST·NASDAQ·Life Sciences·CIK 0001723464

BioHarvest Sciences Inc. is a biotechnology company operating in Israel and the United States, with its base in Vancouver, Canada. The company operates through two segments: Products and CDMO Services. It develops a botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. BioHarvest Sciences Inc. researches, develops, manufactures, markets, and sells science-based health and wellness nutraceutical solutions, which are manufactured and sold as dietary supplements and functional food and beverages. The company also manufactures, markets, and sells science-based health, pharmaceutical, and cosmeceutical solutions. Additionally, it provides contract development and manufacturing operation services. BioHarvest Sciences Inc. offers VINIA, a red grape cell dietary supplement that contains the matrix of polyphenols found in red wine.

BIOHARVEST SCIENCES INC. (NASDAQ:BHST) is a publicly traded company in the Life Sciences sector. Wiseek monitors BHST SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Tate & Lyle Expands BioHarvest Sciences Partnership for Next-Gen Sweetener Innovation
  • Q1 2026 Revenue Up 8% to $8.5M, Net Loss Widens to $2.6M; CDMO Projects Advance
  • Q1 2026 Results Show Increased Net Loss and Going Concern Warning Despite Improved Working Capital
  • BioHarvest Sciences Appoints Experienced VP of Business Development for CDMO Division
  • BioHarvest Sciences Reports Mixed Q1: Revenue Up 8%, Losses Widen Amid CDMO Progress

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$34.51M
Net Income
-$11.13M
Op. Cash Flow
-$7.23M
Free Cash Flow
-$9.58M
Gross Profit
$20.48M
Operating Income
-$5.58M
Cash & Equivalents
$23.02M
Total Debt
$149K
Debt / Equity
0.01×
Net Margin
-32.3%
Source: 40-F · filed 2026-03-31 · accession 0001376474-26-000257

Insider Transactions

BHST files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with B →
$3.2
52-week range · as of 2026-05-14 $3.57 – $12.8
Market cap
$72.54M
Volume
15.2K (0.4× avg)
3-mo avg 34.2K
Live data · 2026-06-14 05:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed BHST - Latest Insights

BHST
May 18, 2026, 7:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $4.10
Real-time Price: $3.20 info
Change: -$0.900 (-22%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 3:59 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.25
Real-time Price: $3.20 info
Change: -$1.05 (-25%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 1:06 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.06
Real-time Price: $3.20 info
Change: -$0.860 (-21%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 10:27 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.06
Real-time Price: $3.20 info
Change: -$0.860 (-21%) info
Market Cap: $72.537M info
BHST
May 14, 2026, 7:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $4.01
Real-time Price: $3.20 info
Change: -$0.805 (-20%) info
Market Cap: $72.537M info
BHST
May 13, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $3.71
Real-time Price: $3.20 info
Change: -$0.510 (-14%) info
Market Cap: $72.537M info
BHST
May 12, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $4.01
Real-time Price: $3.20 info
Change: -$0.810 (-20%) info
Market Cap: $72.537M info
BHST
Apr 29, 2026, 2:09 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.27
Real-time Price: $3.20 info
Change: -$1.07 (-25%) info
Market Cap: $72.537M info
BHST
Mar 31, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
9
Price at Filing: $4.30
Real-time Price: $3.20 info
Change: -$1.10 (-26%) info
Market Cap: $72.537M info
BHST
Mar 26, 2026, 7:30 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $4.36
Real-time Price: $3.20 info
Change: -$1.16 (-27%) info
Market Cap: $72.537M info
BHST
Mar 16, 2026, 2:11 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $4.47
Real-time Price: $3.20 info
Change: -$1.27 (-28%) info
Market Cap: $72.537M info
BHST
Jan 07, 2026, 2:04 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $5.44
Real-time Price: $3.20 info
Change: -$2.23 (-41%) info
Market Cap: $72.537M info